Clazact 2.250 Injection
Marketer
Louis and Clark Pharmaceutical
Salt Composition
Piperacillin (2000mg) + Tazobactum (250mg)
Overview Clazact 2.250 Injection
Clazact 2.250 Injection combines two antibiotics to combat diverse bacterial infections by eliminating harmful microorganisms. Administered solely by healthcare professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity, adhering strictly to their prescribed regimen is crucial. Common side effects can include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and injection site reactions such as pain, swelling, or inflammation. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney or liver impairments to your doctor; adjustments to dosage or alternative medications may be necessary. Generally considered safe under medical supervision during pregnancy and lactation.
Primary Ingredients of Clazact 2.250 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Clazact 2.250 Injection
Infections caused by bacteria
Major Benefits of Clazact 2.250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Clazact 2.250 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Clazact 2.250 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Clazact 2.250 Injection works:
Clazact 2.250 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin combats bacterial growth by disrupting the formation of their protective cell wall. Tazobactum's role is to counteract bacterial resistance mechanisms, thus improving Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Clazact 2.250 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Clazact 2.250 is typically deemed safe for use during gestation. Preclinical trials using animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Clazact 2.250 Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
Clazact 2.250 Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administering Clazact 2.250 Injection requires careful consideration. Dosage modification of Clazact 2.250 Injection might be necessary. A physician's guidance is recommended.
LiverSAFE IF PRESCRIBED
The use of Clazact 2.250 Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Clazact 2.250 Injection :
Forgetting a Clazact 2.250 Injection dose? Seek your physician's advice.
Facts to Know About Clazact 2.250 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |



